Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Greg Brown

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Circulation|January 16, 2002
Coronary collateral size, flow capacity, and growth: estimates from the angiogram in patients with obstructive coronary diseaseJulia Rockstroh, B Greg Brown
Journal of the American College of Cardiology|March 6, 2007
Is intravascular ultrasound the gold standard surrogate for clinically relevant atherosclerosis progression?B Greg Brown, Xue-Qiao Zhao
The American Journal of Cardiology|June 14, 2008
Nicotinic acid, alone and in combinations, for reduction of cardiovascular riskB Greg Brown, Xue-Qiao Zhao
Journal of Clinical Lipidology|February 5, 2011
Should both HDL-C and LDL-C be targets for lipid therapy? A review of current evidenceB Greg Brown, Xue-Qiao Zhao, Marian C Cheung
Current Opinion in Lipidology|November 11, 2006
Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trialsB Greg Brown, Karen Hinckley Stukovsky, Xue-Qiao Zhao
The American Journal of Cardiology|March 20, 2014
Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular diseaseAlberto Zambon, Xue-Qiao Zhao, B Greg Brown, et al.
Journal of Lipid Research|January 13, 2011
Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiographyMilada Dobiásová, Jiri Frohlich, Michaela Sedová, et al.
Journal of Lipid Research|February 4, 2003
Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDLNirupa R Matthan, Ann Giovanni, Ernst J Schaefer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Antioxidant vitamins and lipid therapy: end of a long romance?B Greg Brown, Marian C Cheung, Andrew C Lee, et al.
Journal of Clinical Lipidology|July 2, 2008
Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS)Francesca Vittone, Alan Chait, Josh S Morse, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Circulation|January 16, 2002
Coronary collateral size, flow capacity, and growth: estimates from the angiogram in patients with obstructive coronary diseaseJulia Rockstroh, B Greg Brown
Journal of the American College of Cardiology|March 6, 2007
Is intravascular ultrasound the gold standard surrogate for clinically relevant atherosclerosis progression?B Greg Brown, Xue-Qiao Zhao
The American Journal of Cardiology|June 14, 2008
Nicotinic acid, alone and in combinations, for reduction of cardiovascular riskB Greg Brown, Xue-Qiao Zhao
Journal of Clinical Lipidology|February 5, 2011
Should both HDL-C and LDL-C be targets for lipid therapy? A review of current evidenceB Greg Brown, Xue-Qiao Zhao, Marian C Cheung
Current Opinion in Lipidology|November 11, 2006
Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trialsB Greg Brown, Karen Hinckley Stukovsky, Xue-Qiao Zhao
The American Journal of Cardiology|March 20, 2014
Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular diseaseAlberto Zambon, Xue-Qiao Zhao, B Greg Brown, et al.
Journal of Lipid Research|January 13, 2011
Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiographyMilada Dobiásová, Jiri Frohlich, Michaela Sedová, et al.
Journal of Lipid Research|February 4, 2003
Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDLNirupa R Matthan, Ann Giovanni, Ernst J Schaefer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Antioxidant vitamins and lipid therapy: end of a long romance?B Greg Brown, Marian C Cheung, Andrew C Lee, et al.
Journal of Clinical Lipidology|July 2, 2008
Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS)Francesca Vittone, Alan Chait, Josh S Morse, et al.
Pageof 3